Aemetis (NASDAQ:AMTX) Price Target Raised to $19.00 at Ascendiant Capital Markets

Aemetis (NASDAQ:AMTX) had its price target boosted by Ascendiant Capital Markets from $18.00 to $19.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock.

AMTX has been the topic of a number of other reports. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research note on Wednesday, February 5th. HC Wainwright restated a “buy” rating and set a $28.00 target price on shares of Aemetis in a research report on Friday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $14.56.

Aemetis Stock Up 5.7 %

NASDAQ AMTX opened at $1.68 on Monday. The company has a market cap of $85.94 million, a PE ratio of -0.74 and a beta of 1.48. Aemetis has a 52 week low of $1.50 and a 52 week high of $7.03. The firm’s 50-day simple moving average is $2.18 and its two-hundred day simple moving average is $2.67.

Institutional Trading of Aemetis

Several institutional investors and hedge funds have recently bought and sold shares of AMTX. ProShare Advisors LLC bought a new position in shares of Aemetis in the fourth quarter worth $27,000. Bank of America Corp DE increased its stake in Aemetis by 37.8% in the 4th quarter. Bank of America Corp DE now owns 56,675 shares of the specialty chemicals company’s stock worth $152,000 after acquiring an additional 15,533 shares during the last quarter. Jane Street Group LLC raised its holdings in shares of Aemetis by 1,130.0% in the 4th quarter. Jane Street Group LLC now owns 374,016 shares of the specialty chemicals company’s stock valued at $1,006,000 after acquiring an additional 343,609 shares in the last quarter. Northern Trust Corp raised its holdings in shares of Aemetis by 3.7% in the 4th quarter. Northern Trust Corp now owns 297,023 shares of the specialty chemicals company’s stock valued at $799,000 after acquiring an additional 10,658 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC bought a new stake in shares of Aemetis during the 4th quarter valued at about $227,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.